Anthrax Research Today is a free monthly online journal that collates and summarizes the latest research about Anthrax, including details on bacillus anthracis, contagiousness, exposure, effects.

Volume 1 (2005), Issue 2 (November)

1. Real-time PCR assay for the detection of tanapox virus and yaba-like disease virus.
   J Virol Methods, 130(1): 149-53. [Abstract] [Full-text]
2. Comparison of clarithromycin and ciprofloxacin therapy for Bacillus anthracis Sterne infection in mice with or without (60)Co gamma-photon irradiation.
   J Med Microbiol, 54: 1157-62. [Abstract] [Full-text]
3. A model of anthrax toxin lethal factor bound to protective antigen.
   Proc Natl Acad Sci U S A, 102(45): 16409-14. [Abstract] [Full-text]
4. Robert Koch: the grandfather of cloning?
   Cell, 123(4): 539-42. [Abstract] [Full-text]
5. Advances in alfalfa mosaic virus-mediated expression of anthrax antigen in planta.
   Biochem Biophys Res Commun, 338(2): 717-22. [Abstract] [Full-text]
6. Characterization of Bacillus anthracis germinant receptors in vitro.
   J Bacteriol, 187(23): 8055-62. [Abstract] [Full-text]
7. Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components.
   Vaccine, 23(48): 5688-97. [Abstract] [Full-text]
8. Passive protection against anthrax by using a high-affinity antitoxin antibody fragment lacking an Fc region.
   Infect Immun, 73(12): 8362-8. [Abstract] [Full-text]
9. Direct inhibition of T-lymphocyte activation by anthrax toxins in vivo.
   Infect Immun, 73(12): 8275-81. [Abstract] [Full-text]
10. Plant-based vaccine: mice immunized with chloroplast-derived anthrax protective antigen survive anthrax lethal toxin challenge.
    Infect Immun, 73(12): 8266-74. [Abstract] [Full-text]
11. Whole-cell voltage clamp measurements of anthrax toxin pore current.
    J Biol Chem, 280(47): 39417-22. [Abstract] [Full-text]
12. Beta-cyclodextrin derivatives that inhibit anthrax lethal toxin.
    Bioorg Med Chem, 14(1): 33-40. [Abstract] [Full-text]
13. Effective antimicrobial regimens for use in humans for therapy of Bacillus anthracis infections and postexposure prophylaxis.
    Antimicrob Agents Chemother, 49(12): 5099-106. [Abstract] [Full-text]
14. Effects of spontaneous deamidation on the cytotoxic activity of the Bacillus anthracis protective antigen.
    J Biol Chem, 280(48): 39897-906. [Abstract] [Full-text]
15. Inhibition of platelet aggregation by anthrax edema toxin.
    Biochem Biophys Res Commun, 339(1): 107-14. [Abstract] [Full-text]

© 2005-2008 Anthrax Research Today. All Rights Reserved.